Why the study?
Visceral adipose tissue is an independent risk factor for atherosclerosis and chronic kidney disease, but the effects of chronic subinflammation on decreasing glomerular filtration rate needed summarization.
This systematic review highlights the role of visceral adipose tissue-derived pro-inflammatory cytokines and adipokines in driving chronic subinflammation, atherosclerosis, and chronic kidney disease.
Answers are grounded in this paper and cite their sources.
Supports visceral adiposity screening to refine CVD risk beyond BMI; extends epidemiological evidence linking it to atherosclerosis.
In recent decades, there has been an increase in the prevalence of overweight and obesity. Obesity has become an underestimated pandemic and a public health threat around the world. Adipose tissue is positioned as an endocrine organ that secretes a wide range of pro-inflammatory cytokines and adipokines, inducing a state of chronic subinflammation. The results of epidemiological studies over the past 30 years have also shown that visceral adipose tissue is an independent risk factor for the development of atherosclerosis, cardiometabolic diseases and chronic kidney disease. We performed a systematic review to summarize important aspects of the state of chronic subinflammation in the context of its effect on the decrease in glomerular filtration rate and the development of chronic kidney disease. The review deals with the etiology and pathogenesis of obesity, the hormonal profile of adipose tissue, the molecular mechanisms of the effect of pro-inflammatory cytokines and adipokines on the kidneys, and the pathophysiology of renal diseases. Information on the topic from publications based on the Pubmed database has been used.
No takes yet. Share an insight, caveat, or question.
Ryabova et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: